We have contributed to the establishment of glycobiology as a research field at the University of Oslo, with focus both on molecular biological and clinical aspects.
Our studies in glycobiology have been expanded into research on extracellular matrix in relation to diet related diseases such as diabetes,obesity and atherosclerosis.
We have also published papers on the possible use of proteoglycans and extracellular matrix proteins as markers for kidney changes in diabetes and for endothelial stress.
In several studies we have shown that proteoglycans are important molecules expressed by activated macrophages and activated endothelial cells, with relevance both to inflammation, diabetes and atherosclerosis.
We have also contributed to increased knowledge on proteoglycans as important determinants of tissue integrity in Fish products, together with food scientists.
We have initiated studies on nutrition, health and physical activity in persons with intellectual disabilities, previously not addressed in Norway.